{"id":"https://openalex.org/W2407613667","doi":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","title":"Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia","display_name":"Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2407613667","doi":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","mag":"2407613667","pmid":"https://pubmed.ncbi.nlm.nih.gov/25175964"},"language":"en","primary_location":{"id":"doi:10.1016/b978-0-12-801022-8.00006-4","doi":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","pdf_url":null,"source":{"id":"https://openalex.org/S59060466","display_name":"International review of neurobiology","issn_l":"0074-7742","issn":["0074-7742","2162-5514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Review of Neurobiology","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W641178605","display_name":"Adenosine Receptors in Neurology and Psychiatry"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102101156","display_name":"Tomoyuki Kanda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tomoyuki Kanda","raw_affiliation_strings":["Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan. Electronic address: tomoyuki.kanda@kyowa-kirin.co.jp","Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan. Electronic address: tomoyuki.kanda@kyowa-kirin.co.jp","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102756903","display_name":"Shinichi Uchida","orcid":"https://orcid.org/0009-0009-2704-0065","observed_orcids":["https://orcid.org/0009-0009-2704-0065"]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-ichi Uchida","raw_affiliation_strings":["Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Nervous System R&D Unit, R&D Division, Kyowa Hakko Kirin Co., Ltd., Shizuoka, Japan","institution_ids":["https://openalex.org/I205823427"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102101156"],"corresponding_institution_ids":["https://openalex.org/I205823427"],"apc_list":null,"apc_paid":null,"fwci":12.1214,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.98406989,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"119","issue":null,"first_page":"127","last_page":"150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a2a-receptor-antagonist","display_name":"adenosine A2A receptor antagonists","score":0.9049999713897705},{"id":"https://openalex.org/keywords/dyskinesia","display_name":"dyskinesia","score":0.9610000252723694},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9860000014305115},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.7879999876022339},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.8379999995231628},{"id":"https://openalex.org/keywords/amantadine","display_name":"amantadine","score":0.9110000133514404},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.9225518703460693},{"id":"https://openalex.org/C2777374534","wikidata":"https://www.wikidata.org/wiki/Q409761","display_name":"Amantadine","level":2,"score":0.6049284934997559},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5713826417922974},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5596776008605957},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5350334048271179},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4851582646369934},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.46950411796569824},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4299823045730591},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.40674322843551636},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3709031939506531},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2963910698890686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25719326734542847},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2150682508945465},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2127077281475067}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020820","descriptor_name":"Dyskinesias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020820","descriptor_name":"Dyskinesias","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/b978-0-12-801022-8.00006-4","doi":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-12-801022-8.00006-4","pdf_url":null,"source":{"id":"https://openalex.org/S59060466","display_name":"International review of neurobiology","issn_l":"0074-7742","issn":["0074-7742","2162-5514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Review of Neurobiology","raw_type":"book-chapter"},{"id":"pmid:25175964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25175964","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International review of neurobiology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W47813478","https://openalex.org/W62603772","https://openalex.org/W1493115321","https://openalex.org/W1500797869","https://openalex.org/W1919886056","https://openalex.org/W1964638394","https://openalex.org/W1980202815","https://openalex.org/W1982511121","https://openalex.org/W1982703610","https://openalex.org/W1990269363","https://openalex.org/W2007390314","https://openalex.org/W2009706073","https://openalex.org/W2012557172","https://openalex.org/W2016947344","https://openalex.org/W2019712032","https://openalex.org/W2026475932","https://openalex.org/W2026533497","https://openalex.org/W2028129201","https://openalex.org/W2028285705","https://openalex.org/W2030108063","https://openalex.org/W2031740174","https://openalex.org/W2034588648","https://openalex.org/W2038918555","https://openalex.org/W2039279856","https://openalex.org/W2039647211","https://openalex.org/W2040227196","https://openalex.org/W2042833008","https://openalex.org/W2048729753","https://openalex.org/W2053644967","https://openalex.org/W2065253927","https://openalex.org/W2065648608","https://openalex.org/W2070914201","https://openalex.org/W2073684281","https://openalex.org/W2075021671","https://openalex.org/W2078309607","https://openalex.org/W2078799505","https://openalex.org/W2083868750","https://openalex.org/W2088277236","https://openalex.org/W2088525880","https://openalex.org/W2092175068","https://openalex.org/W2100100055","https://openalex.org/W2106861254","https://openalex.org/W2107574028","https://openalex.org/W2111597060","https://openalex.org/W2115222037","https://openalex.org/W2115639304","https://openalex.org/W2119450744","https://openalex.org/W2120812632","https://openalex.org/W2131371182","https://openalex.org/W2135972980","https://openalex.org/W2136306454","https://openalex.org/W2140463558","https://openalex.org/W2142803792","https://openalex.org/W2146659986","https://openalex.org/W2148975492","https://openalex.org/W2255064238","https://openalex.org/W2335033166","https://openalex.org/W4244194205","https://openalex.org/W6646285811"],"related_works":["https://openalex.org/W7098165551","https://openalex.org/W2129076813","https://openalex.org/W3113588852","https://openalex.org/W2208431235","https://openalex.org/W2088619016","https://openalex.org/W2416708726","https://openalex.org/W2058978764","https://openalex.org/W2201447686","https://openalex.org/W1992289692","https://openalex.org/W2122189667"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}